These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27114972)

  • 1. Periodic Acid-Schiff Staining Parallels the Immunoreactivity Seen By Direct Immunofluorescence in Autoimmune Skin Diseases.
    Abreu Velez AM; Upegui Zapata YA; Howard MS
    N Am J Med Sci; 2016 Mar; 8(3):151-5. PubMed ID: 27114972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease.
    Magro CM; Dyrsen ME
    J Am Acad Dermatol; 2008 Nov; 59(5):822-33. PubMed ID: 19119098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of direct immunofluorescence in dermatological disorders.
    Mysorekar VV; Sumathy TK; Shyam Prasad AL
    Indian Dermatol Online J; 2015; 6(3):172-80. PubMed ID: 26009711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous tinea pedis with direct immunofluorescence positivity: when is a positive result not autoimmune bullous disease?
    Miller DD; Bhawan J
    Am J Dermatopathol; 2013 Jul; 35(5):587-94. PubMed ID: 22892469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic significance of immunofluorescent tests in dermatology].
    Medenica L; Skiljević D
    Med Pregl; 2009; 62(11-12):539-46. PubMed ID: 20491380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Clinical and Laboratory Use of the Cutaneous Direct Immunofluorescence Assay.
    Reimann JDR; Moynihan SP; Horn TD
    JAMA Dermatol; 2021 Nov; 157(11):1343-1348. PubMed ID: 34613346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience.
    Arbache ST; Nogueira TG; Delgado L; Miyamoto D; Aoki V
    An Bras Dermatol; 2014; 89(6):885-9. PubMed ID: 25387492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing The Efficacy of Hematoxylin and Eosin, Periodic Acid Schiff and Fluorescent Periodic Acid Schiff-Acriflavine Techniques for Demonstration of Basement Membrane in Oral Lichen Planus: A Histochemical Study.
    Pujar A; Pereira T; Tamgadge A; Bhalerao S; Tamgadge S
    Indian J Dermatol; 2015; 60(5):450-6. PubMed ID: 26538690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cross-sectional Study of Direct Immunofluorescence in the Diagnosis of Immunobullous Dermatoses.
    Buch AC; Kumar H; Panicker N; Misal S; Sharma Y; Gore CR
    Indian J Dermatol; 2014 Jul; 59(4):364-8. PubMed ID: 25071256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoperoxidase staining for the detection of autoantibodies in canine autoimmune skin disease; comparison to immunofluorescence results.
    Bradley GA; Mays MB
    Vet Immunol Immunopathol; 1990 Oct; 26(2):105-13. PubMed ID: 2260277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
    Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
    Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous lupus erythematosus: direct immunofluorescence and epidermal basal membrane study.
    Sugai SA; Gerbase AB; Cernea SS; Sotto MN; Oliveira ZN; Vilela MA; Rivitti EA; Miyauchi LM; Sampaio SA
    Int J Dermatol; 1992 Apr; 31(4):260-4. PubMed ID: 1378820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of annular erythema without bullous lesions by autoimmune blistering diseases.
    Kabuto M; Fujimoto N; Tanaka T
    Mod Rheumatol; 2018 Jan; 28(1):200-202. PubMed ID: 26382039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A predominant IgG4 subclass may be responsible for false-negative direct immunofluorescence in bullous pemphigoid.
    Buschman KE; Seraly M; Thong HY; Deng JS; Draviam RP; Abernethy JL
    J Cutan Pathol; 2002 May; 29(5):282-6. PubMed ID: 12100628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
    Sami N; Ahmed AR
    Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune bullous skin diseases].
    Joly P
    Rev Med Interne; 1999 Jan; 20(1):26-38. PubMed ID: 10220817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid.
    Cozzani E; Drosera M; Parodi A; Carrozzo M; Gandolfo S; Rebora A
    Acta Derm Venereol; 2004; 84(5):381-4. PubMed ID: 15370705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunofluorescence Patterns in Selected Dermatoses, Including Blistering Skin Diseases Utilizing Multiple Fluorochromes.
    Abreu-Velez AM; Calle-Isaza J; Howard MS
    N Am J Med Sci; 2015 Sep; 7(9):397-402. PubMed ID: 26605203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clinicopathological Study of Pemphigus in Eastern India with Special Reference to Direct Immunofluorescence.
    Chowdhury J; Datta PK; Chowdhury SN; Das NK
    Indian J Dermatol; 2016; 61(3):288-94. PubMed ID: 27293249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.